| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3189688 | Annales de Dermatologie et de Vénéréologie | 2007 | 4 Pages |
Abstract
There appear to be no rational grounds for discontinuing antiplatelet therapy in advance of skin cancer surgery involving loss of skin of up to 10 cm in diameter.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
A. Danino, A. Duvernay, R. Dautriche, R. Duvernay-Debin, Y. Cottin, S. Dalac,